Myasthenia gravis and monoclonal IgG gammopathy
暂无分享,去创建一个
[1] G Matell,et al. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. , 1978, Journal of neurology, neurosurgery, and psychiatry.
[2] U. Axelsson. An eleven-year follow-up on 64 subjects with M-components. , 2009, Acta Medica Scandinavica.
[3] A. Lefvert,et al. Immunoglobulins in myasthenia gravis: effect of human lymph IgG 3 and F(ab‘)2 fragments on a cholinergic receptor preparation from Torpedo marmorata * , 1977, European journal of clinical investigation.
[4] J. Lindstrom. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. , 1977, Clinical immunology and immunopathology.
[5] J. Davis,et al. REMISSION OF MYASTHENIA GRAVIS FOLLOWING PLASMA-EXCHANGE , 1976, The Lancet.
[6] J. Lindstrom,et al. Antibody to acetylcholine receptor in myasthenia gravis , 1976, Neurology.
[7] L. Hughes. Benign to malignant. , 1976, Clinical oncology.
[8] A. Pestronk,et al. Myasthenia gravis: passive transfer from man to mouse , 1975, Science.
[9] R. Almon,et al. Acetylcholine receptor antibodies in myasthenia gravis. , 1975, The New England journal of medicine.
[10] S. Fuchs,et al. HUMORAL ANTIBODIES TO ACETYLCHOLINE RECEPTOR IN PATIENTS WITH MYASTHENIA GRAVIS , 1975, The Lancet.
[11] L. Gattegno,et al. Antibodies against myoid thymic cells and striated muscle, and monoclonal gammapathy in myasthenia gravis. , 1975, Biomedicine / [publiee pour l'A.A.I.C.I.G.].
[12] B. Nilsson,et al. Drainage of thoracic duct lymph in twelve patients with myasthenia gravis. , 1975, European neurology.
[13] W. C. Levin,et al. Idiopathic (asymptomatic) monoclonal gammopathies. , 1975, Archives of Internal Medicine.
[14] H. Lackner. Hemostatic abnormalities associated with dysproteinemias. , 1973, Seminars in hematology.
[15] E. Osserman,et al. PATHOLOGIC CONDITIONS ASSOCIATED WITH PLASMA CELL DYSCRASIAS: A STUDY OF 806 CASES * , 1971, Annals of the New York Academy of Sciences.
[16] A. Papatestas,et al. The Relationship Between Thymus and Oncogenesis , 1971, British Journal of Cancer.
[17] M. Potter. Myeloma proteins (M-components) with antibody-like activity. , 1971, The New England journal of medicine.
[18] C. Alper,et al. Immunofixation Electrophoresis: A Technique for the Study of Protein Polymorphism 1 , 1969, Vox sanguinis.
[19] L. Rowland,et al. Myasthenia gravis with a myeloma-type, gamma-G (IgG) immunoglobulin abnormality. , 1969, The American journal of medicine.
[20] R. Williams,et al. Thymoma associated with multiple myeloma. , 1968, Archives of internal medicine.
[21] J. Harley,et al. Thymoma, plasma cell myeloma, red cell aplasia and malabsorption syndrome. , 1968, The American journal of medicine.
[22] U. Axelsson,et al. Frequency of pathological proteins (M-components) om 6,995 sera from an adult population. , 2009, Acta medica Scandinavica.
[23] D. McFarlin,et al. DOES MYASTHENIC SERUM BIND TO THE NEUROMUSCULAR JUNCTION? , 1966, Annals of the New York Academy of Sciences.
[24] J. Heremans,et al. Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.
[25] H. Goodman,et al. IMMUNOLOGICAL CONCOMITANTS OF MYASTHENIA GRAVIS , 1965, Annals of the New York Academy of Sciences.
[26] T. Feltkamp,et al. Myasthenia gravis with hypergammaglobulinaemia and antibodies , 1964, Journal of neurology, neurosurgery, and psychiatry.
[27] J. Simpson. Myasthenia Gravis: A New Hypothesis , 1960 .